New drug trial targets Hard-to-Treat cancers

NCT ID NCT05719558

Recruiting now Disease control Sponsor: Astellas Pharma Global Development, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 21 times

Summary

This early-stage study tests a new drug called ASP1002 in adults with advanced solid tumors that have spread and have high levels of a protein called claudin 4. The main goals are to check the drug's safety, find the best dose, and see how well people tolerate it. Participants receive the drug through an IV infusion weekly, every two weeks, or every three weeks for up to two years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut
RECRUITING

Plainville, Connecticut, 06062, United States
HealthPartners Cancer Research Center
RECRUITING

Saint Paul, Minnesota, 55101, United States
Henry Ford Hospital
RECRUITING

Detroit, Michigan, 48202, United States
Icahn School of Medicine at Mount Sinai
RECRUITING

New York, New York, 10029, United States
Mary Crowley Cancer Research Center
RECRUITING

Dallas, Texas, 75251, United States
NEXT Oncology Virginia
RECRUITING

Fairfax, Virginia, 22031, United States
Norton Cancer Institute
RECRUITING

Louisville, Kentucky, 40202, United States
Prisma Health-Upstate Cancer Institute
COMPLETED

Greenville, South Carolina, 29605, United States
SCRI Oncology Partners
COMPLETED

Nashville, Tennessee, 37203, United States
Swedish Cancer Institute
RECRUITING

Edmonds, Washington, 21632, United States
University Hospitals of Cleveland
RECRUITING

Cleveland, Ohio, 44106, United States
University of Florida
RECRUITING

Gainesville, Florida, 32610, United States
University of Iowa Hospitals
RECRUITING

Iowa City, Iowa, 52242, United States
University of Texas Southwestern
COMPLETED

Dallas, Texas, 75235, United States
Yale University Cancer Center
RECRUITING

New Haven, Connecticut, 06520, United States

Conditions

Explore the condition pages connected to this study.

ADVANCED SOLID TUMORS ADVANCED SOLID TUMORS